Systemic antibodies administered by passive immunization prevent generalization of the infection by foot-and-mouth disease virus in cattle after oronasal challenge.
Barrionuevo F, Di Giacomo S, Bucafusco D, Ayude A, Schammas J, Miraglia MC, Capozzo A, Borca MV, Perez-Filgueira M.
Virology. 2018 May;518:143-151. doi: 10.1016/j.virol.2018.02.012. Epub 2018 Mar 15.
[Vaccination in advanced age].
Heppner HJ, Leischker A, Wutzler P, Kwetkat A.
Internist (Berl). 2018 Feb;59(2):205-212. doi: 10.1007/s00108-017-0358-1.
Duration of immunity against pertussis after natural infection or vaccination.
Wendelboe AM, Van Rie A, Salmaso S, Englund JA.
Pediatr Infect Dis J. 2005 May;24(5 Suppl):S58-61. doi: 10.1097/01.inf.0000160914.59160.41.
Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection.
Ronan EO, Lee LN, Beverley PC, Tchilian EZ.
PLoS One. 2009 Dec 9;4(12):e8235. doi: 10.1371/journal.pone.0008235.
Maternal immunization with pneumococcal surface protein A provides the immune memories of offspring against pneumococcal infection.
Kono M, Iyo T, Murakami D, Sakatani H, Nanushaj D, Hotomi M.
Front Cell Infect Microbiol. 2023 Mar 23;13:1059603. doi: 10.3389/fcimb.2023.1059603. eCollection 2023.
Effects of oil-based adjuvants on the immune response of pigs after dermal administration of antigen and evaluation of the immunization level after a subsequent Actinobacillus pleuropneumoniae challenge in pigs.
Jarosova R, Ben Arous J, Nechvatalova K, Nedbalcova K, Hlavova K, Stepanova H, Leva L, Oreskovic Z, Jan Matiasovic, Versillé N, Sladek Z, Faldyna M.
Vet Microbiol. 2023 Jan;276:109607. doi: 10.1016/j.vetmic.2022.109607. Epub 2022 Nov 30.
COVID-19 and plasma cells: Is there long-lived protection?
Nguyen DC, Lamothe PA, Woodruff MC, Saini AS, Faliti CE, Sanz I, Lee FE.
Immunol Rev. 2022 Aug;309(1):40-63. doi: 10.1111/imr.13115. Epub 2022 Jul 8.
Protection against Mycoplasma hyorhinis infection in commercial pigs via immunization with inactivated vaccines prepared with homologous or heterologous strains.
Wang J, Gan Y, Yuan T, Huang Y, Zhang L, Wei Y, Zubair M, Wang L, Chen J, Shao G, Feng Z, Xiong Q.
Vaccine. 2024 Dec 2;42(26):126421. doi: 10.1016/j.vaccine.2024.126421. Epub 2024 Oct 9.
Vaccines in Patients with Primary Immune Deficiency.
Bonilla FA.
Immunol Allergy Clin North Am. 2020 Aug;40(3):421-435. doi: 10.1016/j.iac.2020.03.004.
In vitro correlates of cell-mediated immunity in human tonsils after natural or induced Rubella virus infection.
Morag A, Morag B, Bernstein JM, Beutner K, Ogra PL.
J Infect Dis. 1975 Apr;131(4):409-16. doi: 10.1093/infdis/131.4.409.
